MAGEA1 and neoplasm: The inhibited expression of many CTAs (such as NY‐ESO‐1, MAGE‐A1, and MAGE‐A3) in tumor cells is consistent with DNA hypermethylation and histone heterochromatin modification in the promoters of these genes.